Back to search

Article

Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: A qualitative study

2026-05-08

Abstract excerpt

<h4>Background</h4> Subcutaneous oncology monoclonal antibodies (SCOmAbs) offer significant benefits compared to intravenous formulations, including reduced administration time and potential for self-administration. However, little has been published on real-world preparation and administration practices with these novel formulations. <h4>Methods</h4> This was a qualitative, exploratory study of 30 participants...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0612426b-f5a2-5d96-b8fa-2182b4ce18cd
DOI
10.64898/2026.05.06.26352582
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: A qualitative studyDOI 10.64898/2026.05.06.26352582
Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient-reported outcomesSemantic proximity
Subcutaneous administration for symptom control in Primary Care: a scoping review and a nurse-led conceptual implementation roadmapSemantic proximity
Driving adoption of new technologies in biopharmaceutical manufacturingSemantic proximity
Beyond QTPP: Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube MedicationsSemantic proximity
Cancer Immunotherapy Implementation in Crisis-Affected MENA Settings (Lebanon, Sudan, and Iraq): A Pilot Descriptive-Analytical Cross-Sectional Study of Barriers, Clinical Readiness, and Policy PrioritiesSemantic proximity
Fully Integrated downstream process to enable Next Generation ManufacturingSemantic proximity
Frequency and component analysis of contaminants generated in preparation of anticancer agents using Closed system drug transfer devices (CSTDs)Semantic proximity
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment.Semantic proximity
Intrathecal Drug Delivery (ITDD) systems for cancer painSemantic proximity
Towards a commercial process for the manufacture of genetically modified T cells for therapySemantic proximity
Development of a Precision Medicine Competency Framework for the Therapeutics IndustrySemantic proximity
Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital settingSemantic proximity
Select a neighboring publication to make it the new centre.